We have located links that may give you full text access.
Echocardiographic Findings Associated with Transplant-free Survival and Left Ventricular Systolic Function at Mid-term Follow-up after Ross Procedure in Infants with Critical Aortic Stenosis.
Journal of the American Society of Echocardiography 2020 December 30
BACKGROUND: The Ross operation is an important option for children with critical aortic stenosis (CAS) with residual disease, but operation in infancy is associated with significant morbidity and mortality. We evaluated echocardiographic correlates of transplant-free survival, re-intervention, and left ventricular (LV) function in mid-term follow-up.
METHODS: This retrospective, single-center study included all infants with CAS who underwent Ross by 1 year of age from 1/2000 to 9/2018. Serial echocardiograms were analyzed for LV ejection fraction (EF) and systolic and diastolic longitudinal strain (LS). The primary outcome was mortality or transplant; secondary outcomes were re-intervention and abnormal LVEF (≤55%).
RESULTS: In 40 infants (30 [75%] male; median age at Ross 51 days) with median follow-up 3.3 years (interquartile range 1.0-9.4), the primary outcome was met in 11/40 (28%). Transplant-free survival was 79%, 77%, and 69% at 1, 5, and 10 years post Ross. Predictors of transplant or death included neonatal surgery, cross-clamp time, and pre-operative left atrial dilatation and lower LVEF. Median freedom from re-intervention was at 7.1 years post Ross, with no identified associations. LV LS improved 1 year post-Ross (-21.1±3.8% vs. -17.4±5.1%, p=0.02), although LVEF did not reach significance. Lower LVEF at 1 year was related to pre-Ross LA dilatation (p=0.02), abnormal LVEF (p=0.04), and lower early diastolic LS rate (p=0.03). LVEF remained stable 3-years post Ross.
CONCLUSION: Both transplant-free survival and normalization of LV function post Ross in infancy are associated with pre-operative LV systolic and diastolic measures, highlighting the prognostic value of echocardiography in this population. Further data are necessary in a larger, multicenter cohort, to allow for more precise risk stratification.
METHODS: This retrospective, single-center study included all infants with CAS who underwent Ross by 1 year of age from 1/2000 to 9/2018. Serial echocardiograms were analyzed for LV ejection fraction (EF) and systolic and diastolic longitudinal strain (LS). The primary outcome was mortality or transplant; secondary outcomes were re-intervention and abnormal LVEF (≤55%).
RESULTS: In 40 infants (30 [75%] male; median age at Ross 51 days) with median follow-up 3.3 years (interquartile range 1.0-9.4), the primary outcome was met in 11/40 (28%). Transplant-free survival was 79%, 77%, and 69% at 1, 5, and 10 years post Ross. Predictors of transplant or death included neonatal surgery, cross-clamp time, and pre-operative left atrial dilatation and lower LVEF. Median freedom from re-intervention was at 7.1 years post Ross, with no identified associations. LV LS improved 1 year post-Ross (-21.1±3.8% vs. -17.4±5.1%, p=0.02), although LVEF did not reach significance. Lower LVEF at 1 year was related to pre-Ross LA dilatation (p=0.02), abnormal LVEF (p=0.04), and lower early diastolic LS rate (p=0.03). LVEF remained stable 3-years post Ross.
CONCLUSION: Both transplant-free survival and normalization of LV function post Ross in infancy are associated with pre-operative LV systolic and diastolic measures, highlighting the prognostic value of echocardiography in this population. Further data are necessary in a larger, multicenter cohort, to allow for more precise risk stratification.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app